A

SELL

Agilent Technologies, Inc.

Healthcare · Rank #123 · Analyzed Oct 18, 2026

$172.97

Current Price

$49.70

Intrinsic Value

-71.3%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 71.3%

Fair Value Range

Low$38.38

Base (IV)$49.70

High$58.90

Entry Points

Conservative$26.87

Moderate$38.38

Aggressive$34.79

Quality & Moat Breakdown

Return on Equity21.0% → 1.0/1.0

Debt LevelD/E 56 → 0.5/1.0

Revenue QualityGrowth 11.1%, margin Δ-8.6% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins19.5% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.